Bioxiness Pharmaceuticals is a California-based pre-clinical stage company, developing a novel class of antimicrobial compounds for the treatment of severe bacterial infections. Bioxiness compounds are new chemical class (NCC) developed towards critical target-enzymes within the pathogenic bacterial cells. These molecules employ unique mode of